Announcement

The physical space of the MSK Library at 430 E 67th St has closed to visitors effective Friday, May 17, 2024 in preparation for the construction of MSK's new cancer care Pavilion.  Please visit this guide for more information. The library's services continue to be available online.

 




 
MSK Archives

Learn more about this service.


News & Events
  • New NIH Data Management and Sharing Seminar
    Been meaning to incorporate a time-saving citation management tool into your research/writing process? Check out your software and training options in the MSK Library Guide Citation Management.
  • Request a custom Synapse group for your department
    MSK has a rich history dating back to 1884 and the MSK Archives holds records detailing this history. Learn more on our new MSK Archives Library Guide
  • Graph depicting rates of cancer by gender
    Thinking about embarking on a review? We’ve launched a new guide for our Systematic Review Service! Learn more via our blog.  
     
  • The MSK Library’s physical space at 430 E 67th St is now closed in preparation for the construction of MSK’s new cancer care Pavilion. The MSK Library’s online services are not affected. Visit this guide for more information on this closure.
  • Get help with a literature search
    ClinicalKey has been added to the MSK Library’s roster of Evidence Based Point of Care/Clinical Decision Support Resources. Use it for “quick answers at the point of care” or to access “leading full-text reference material”.
MSK Library Guides
custom information guides

Citation Management

Software overview, tutorials & support

Evidence-Based Practice

Defining PICO, finding evidence & N-CARE support

NIH Data Management & Sharing Policy

Information, resources & support

NIH Public Access Policy

Info & guidance for complying

Support for Authors

Information, resources & support

See all


Today's Science Sparks
Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC.  Fig 2. Waterfall plot of best percentage change in the sum of diameters from baseline for the pooled HER3-DXd 5.6-mg/kg patients who had prior third-generation EGFR TKI therapy and prior platinum-based chemotherapy
Yu, HA, Baik, C, Kim, DW, Johnson, ML, Hayashi, H, Nishio, M, Yang, JC, Su, WC, Gold, KA, Koczywas, M, Smit, EF, Steuer, CE, Felip, E, Murakami, H, Kim, SW, Su, X, Sato, S, Fan, PD, Fujimura, M, Tanaka, Y, Patel, P, Sternberg, DW, Sellami, D, Jänne, PA
Synapse
MSK's DISTINGUISHED AUTHORS